Caroline Barelle | Chief Executive Officer
Elasmogen

With postgraduate qualifications in both business and science, Caroline has a strong commercial, bio-partnering and biologics drug discovery/development background.  She has successfully led teams at Wyeth Inc and subsequently Pfizer Inc in Global Bio-therapeutic Technologies progressing early platform technologies to late stage clinical development. Prior to this she was Alliance and Programs Manager at Haptogen Ltd and a key part of the acquisition team that successfully exited the business to Wyeth Inc. She is a member of the Enterprise, Skills and Strategy Board (ESSB), the Opportunity North East Board (ONE), the RS Entrepreneur in Residence for Queen’s University Belfast and sits on the Royal Society Science, Industry and Translation Committee.   She has been awarded a prestigious Royal Society of Edinburgh commercialisation Fellowship and is a doctoral graduate from the University of Aberdeen in Biochemistry and has an MBA from Robert Gordon University.